Lite Strategy, Inc. Depreciation
Lite Strategy, Inc. (LITS) reported Depreciation of $100.00 thousand for the 12-month period ending 2024-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-09-26
- Lite Strategy, Inc. depreciation for the quarter ending 2024-03-31 was $86.00K, a 11.34% decline year-over-year.
- Lite Strategy, Inc. depreciation for the quarter ending 2023-12-31 was $85.00K, a 7.61% decline year-over-year.
- Lite Strategy, Inc. depreciation for the quarter ending 2023-03-31 was $97.00K.
- Lite Strategy, Inc. depreciation for the quarter ending 2022-12-31 was $92.00K.
- Lite Strategy, Inc. depreciation for fiscal 2024 was $100.00K.
- Lite Strategy, Inc. depreciation for fiscal 2022 was $326.00K, a 88.56% decline from fiscal 2021.
- Lite Strategy, Inc. depreciation for fiscal 2021 was $2.85M, a 3700.00% increase from fiscal 2020.
- Lite Strategy, Inc. depreciation for fiscal 2020 was $75.00K, a 66.67% increase from fiscal 2019.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed | Depreciation 130 month | Depreciation 133 month | Depreciation 136 month | Depreciation 139 month |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $100.00K 10-K · filed 2025-09-26 | ||||||||
| 2024-03-31 | $86.00K 10-Q · filed 2024-05-09 | $171.00K derived: sum of 2 quarters · filed 2024-05-09 | |||||||
| 2023-12-31 | $85.00K 10-Q · filed 2024-02-13 | ||||||||
| 2023-03-31 | $97.00K 10-Q · filed 2024-05-09 | $189.00K derived: sum of 2 quarters · filed 2024-05-09 | |||||||
| 2022-12-31 | $92.00K 10-Q · filed 2024-02-13 | ||||||||
| 2022-06-30 | $326.00K 10-K · filed 2022-09-08 | ||||||||
| 2021-06-30 | $2.85M 10-K · filed 2022-09-08 | $285.00K 10-K · filed 2021-09-02 | |||||||
| 2020-06-30 | $75.00K 10-K · filed 2022-09-08 | ||||||||
| 2019-06-30 | $45.00K 10-K/A · filed 2022-05-23 | ||||||||
| 2018-06-30 | $18.00K 10-K · filed 2020-09-09 | ||||||||
| 2017-06-30 | $50.00K 10-K · filed 2019-08-28 | ||||||||
| 2016-06-30 | $23.00K 10-K · filed 2018-08-30 | ||||||||
| 2015-06-30 | $30.00K 10-K · filed 2017-09-05 | ||||||||
| 2014-06-30 | $15.00K 10-K · filed 2016-09-06 | ||||||||
| 2013-06-30 | $15.00K 10-K · filed 2015-09-02 | ||||||||
| 2012-06-30 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-09 | $6.00K derived: sum of 2 quarters · filed 2014-09-09 | $10.00K derived: sum of 3 quarters · filed 2014-09-09 | $13.00K 10-K · filed 2014-09-09 | $26.00K 10-K · filed 2012-09-18 | ||||
| 2012-03-31 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $7.00K derived: sum of 2 quarters · filed 2012-05-15 | $10.00K 10-Q · filed 2012-05-15 | $13.00K derived: sum of 4 quarters · filed 2012-09-18 | $23.00K 10-Q · filed 2012-05-15 | ||||
| 2011-12-31 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | $7.00K 10-Q · filed 2012-02-09 | $10.00K derived: sum of 3 quarters · filed 2012-09-18 | $14.00K derived: sum of 4 quarters · filed 2012-09-18 | $20.00K 10-Q · filed 2012-02-09 | ||||
| 2011-09-30 | $3.00K 10-Q · filed 2011-11-14 | $6.00K derived: sum of 2 quarters · filed 2012-09-18 | $10.00K derived: sum of 3 quarters · filed 2012-09-18 | $13.00K derived: sum of 4 quarters · filed 2012-09-18 | $16.00K 10-Q · filed 2011-11-14 | ||||
| 2011-06-30 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-18 | $7.00K derived: sum of 2 quarters · filed 2012-09-18 | $10.00K derived: sum of 3 quarters · filed 2012-09-18 | $13.00K 10-K · filed 2012-09-18 | |||||
| 2011-03-31 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $7.00K derived: sum of 2 quarters · filed 2012-05-15 | $10.00K 10-Q · filed 2012-05-15 | ||||||
| 2010-12-31 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | $6.00K 10-Q · filed 2012-02-09 | |||||||
| 2010-09-30 | $3.00K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |